The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses. Phase 1: Use of a Potent Agonist and a Potent Antagonist to Test the Standardized Protocol

The Organisation for Economic Cooperation and Development (OECD) has completed phase 1 of the Hershberger validation intended to identify in vivo activity of suspected androgens and anti-androgens. Seventeen laboratories from 7 countries participated in phase 1, and results were collated and evaluated by the OECD with the support of an international committee of experts. Five androgen-responsive tissues (ventral prostate, paired seminal vesicles and coagulating glands, levator ani and bulbocavernosus muscles, glans penis, and paired Cowper’s or bulbourethral glands) were evaluated. The standardized protocols used selected doses of a reference androgen, testosterone propionate (TP), and an antiandrogen, flutamide (FLU). All laboratories successfully detected TP-stimulated increases in androgen-responsive tissue weight and decreases in TP-stimulated tissue weights when FLU was co-administered. The standardized protocols performed well under a variety of conditions (e.g., strain, diet, housing protocol, bedding). There was good agreement among laboratories with regard to the TP doses inducing significant increases in tissue weights and the FLU doses decreasing TP-stimulated tissue weights. Several additional procedures (e.g., weighing of the dorsolateral prostate and fixation of tissues before weighing) and serum component measurements (e.g., luteinizing hormone) were also included by some laboratories to assess their potential utility. The results indicated that the OECD Hershberger protocol was robust, reproducible, and transferable across laboratories. Based on this phase 1 validation study, the protocols have been refined, and the next phase of the OECD validation program will test the protocol with selected doses of weak androgen agonists, androgen antagonists, a 5α-reductase inhibitor, and chemicals having no androgenic activity.

[1]  P. Stolpman,et al.  Environmental Protection Agency , 2020, The Grants Register 2022.

[2]  William Owens,et al.  The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies. , 2003, Environmental health perspectives.

[3]  J Ashby,et al.  The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. , 2001, Environmental health perspectives.

[4]  L. Gray,et al.  Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. , 2000, Toxicological Sciences.

[5]  T. Sukata,et al.  Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  J. Ashby,et al.  Preliminary Evaluation of the Major Protocol Variables for the Hershberger Castrated Male Rat Assay for the Detection of Androgens, Antiandrogens, and Metabolic Modulators , 2000 .

[7]  L. G. Davis,et al.  Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  R. Tyl,et al.  Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. , 1997, Reproductive toxicology.

[9]  Peter R. Nelson,et al.  Multiple Comparisons: Theory and Methods , 1997 .

[10]  R. Neri,et al.  On the Mechanism of the Anti-androgenic Action ofFlutamide (α-α-α-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide)in the Rat , 1974 .

[11]  E. Bloch,et al.  Studies on the inhibition of fetal androgen formation. Inhibition of testosterone synthesis in rat and rabbit fetal testes with observations on reproductive tract development. , 1971, Endocrinology.

[12]  A. Goldman Production of hypospadias in the rat by selective inhibition of fetal testicular 17 alpha-hydroxylase and C17-20-lyase. , 1971, Endocrinology.

[13]  F. Neumann,et al.  Development of a vagina in male rats by inhibiting androgen receptors with an anti-androgen during the critical phase of organogenesis. , 1966, Endocrinology.

[14]  Charles W. Dunnett,et al.  New tables for multiple comparisons with a control. , 1964 .

[15]  P. W. Bowman,et al.  PHS Public Health Service , 1963 .

[16]  C. Dunnett A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[17]  R. K. Meyer,et al.  Myotrophic Activity of 19-Nortestosterone and Other Steroids Determined by Modified Levator Ani Muscle Method.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  G. Gordan,et al.  The levator ani muscle of the rat as an index of myotrophic activity of steroidal hormones. , 1950, The Journal of pharmacology and experimental therapeutics.

[19]  G. Gordan,et al.  Testosterone and tissue respiration of the castrate male rat with a possible test for myotrophic activity. , 1949, Endocrinology.

[20]  Organisation for Economic Cooperation and Development,et al.  Organisation for economic cooperation and development , 1998 .

[21]  F. Neumann,et al.  Aspects of androgen-dependent events as studied by antiandrogens. , 1970, Recent progress in hormone research.

[22]  J. Freud,et al.  Conditions of hypertrophy of seminal vesicles in rats: The effect of derivatives of oestrone (menformon). , 1934, The Biochemical journal.

[23]  J. Freud,et al.  Conditions of hypertrophy of the seminal vesicles in rats. , 1933, The Biochemical journal.

[24]  V. Korenchevsky The assay of testicular hormone preparations. , 1932, The Biochemical journal.

[25]  V. Korenchevsky,et al.  The response of castrated male rats to the injection of testicular hormone. , 1932, The Biochemical journal.